Chris Leamon

Chris Leamon

Company: Advanced Accelerator Applications

Job title: Indiana Site Head, Vice President of Discovery Research

Seminars:

Panel Discussion: Beyond PSMA – How Do We Realistically Identify New Targets to Take on with Radioligand Therapy 11:30 am

The success of Lutathera has re-demonstrated the value of RLT and provided another the proof of concept for this drug modality It is essential for the industry to maintain this momentum and look to the future and find the next generation of targets so that we can properly assess their potential value This session therefore…Read more

day: Day Two

A Closer Look Into Ligand Targeted Radiotherapy 11:00 am

Payloads: advantages of RLT over targeted chemo Hear an update on 177Lu-PSMA-617 development for mCRPC Gain a peek at a new RLT moleculeRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.